James Mohler, MD | Authors

Articles

Improving the Efficacy of Abiraterone

March 26, 2014

James Mohler, MD, chair, Department of Urology, associate director, Translational Research, Roswell Park Cancer Institute, discusses how his laboratory is working to improve the efficacy of abiraterone for the treatment of prostate cancer.